150 related articles for article (PubMed ID: 33743997)
1. Inability of Radioiodine Remnant Ablation to Improve Postoperative Outcome in Adult Patients with Low-Risk Papillary Thyroid Carcinoma.
Hay ID; Kaggal S; Iniguez-Ariza NM; Reinalda MS; Wiseman GA; Thompson GB
Mayo Clin Proc; 2021 Jul; 96(7):1727-1745. PubMed ID: 33743997
[TBL] [Abstract][Full Text] [Related]
2. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients.
Hay ID; Thompson GB; Grant CS; Bergstralh EJ; Dvorak CE; Gorman CA; Maurer MS; McIver B; Mullan BP; Oberg AL; Powell CC; van Heerden JA; Goellner JR
World J Surg; 2002 Aug; 26(8):879-85. PubMed ID: 12016468
[TBL] [Abstract][Full Text] [Related]
3. Radioiodine remnant ablation in stage I adult papillary thyroid carcinoma: does it improve postoperative outcome?
Hay ID; Kaggal S; Thompson GB
Eur Thyroid J; 2022 Aug; 11(4):. PubMed ID: 35713242
[TBL] [Abstract][Full Text] [Related]
4. Managing patients with papillary thyroid carcinoma: insights gained from the Mayo Clinic's experience of treating 2,512 consecutive patients during 1940 through 2000.
Hay ID; McConahey WM; Goellner JR
Trans Am Clin Climatol Assoc; 2002; 113():241-60. PubMed ID: 12053713
[TBL] [Abstract][Full Text] [Related]
5. Papillary Thyroid Carcinoma (PTC) in Children and Adults: Comparison of Initial Presentation and Long-Term Postoperative Outcome in 4432 Patients Consecutively Treated at the Mayo Clinic During Eight Decades (1936-2015).
Hay ID; Johnson TR; Kaggal S; Reinalda MS; Iniguez-Ariza NM; Grant CS; Pittock ST; Thompson GB
World J Surg; 2018 Feb; 42(2):329-342. PubMed ID: 29030676
[TBL] [Abstract][Full Text] [Related]
6. Clinical Outcomes after Early and Delayed Radioiodine Remnant Ablation in Patients with Low-Risk Papillary Thyroid Carcinoma: Propensity Score Matching Analysis.
Ahn J; Jin M; Song E; Jeon MJ; Kim TY; Ryu JS; Kim WB; Shong YK; Han JM; Kim WG
Endocrinol Metab (Seoul); 2020 Dec; 35(4):830-837. PubMed ID: 33202517
[TBL] [Abstract][Full Text] [Related]
7. The results of selective use of radioactive iodine on survival and on recurrence in the management of papillary thyroid cancer, based on Memorial Sloan-Kettering Cancer Center risk group stratification.
Nixon IJ; Ganly I; Patel SG; Palmer FL; Di Lorenzo MM; Grewal RK; Larson SM; Tuttle RM; Shaha A; Shah JP
Thyroid; 2013 Jun; 23(6):683-94. PubMed ID: 23742290
[TBL] [Abstract][Full Text] [Related]
8. Radioiodine remnant ablation in low-risk differentiated thyroid cancer.
Saengsuda Y
J Med Assoc Thai; 2013 May; 96(5):614-24. PubMed ID: 23745318
[TBL] [Abstract][Full Text] [Related]
9. Lack of Efficacy of Radioiodine Remnant Ablation for Papillary Thyroid Microcarcinoma: Verification Using Inverse Probability of Treatment Weighting.
Kwon H; Jeon MJ; Kim WG; Park S; Kim M; Kim TY; Han M; Song DE; Sung TY; Yoon JH; Hong SJ; Ryu JS; Shong YK; Kim WB
Ann Surg Oncol; 2017 Sep; 24(9):2596-2602. PubMed ID: 28600731
[TBL] [Abstract][Full Text] [Related]
10. Radioiodine Uptake and Thyroglobulin-Guided Radioiodine Remnant Ablation in Patients with Differentiated Thyroid Cancer: A Prospective, Randomized, Open-Label, Controlled Trial.
Jin Y; Ruan M; Cheng L; Fu H; Liu M; Sheng S; Chen L
Thyroid; 2019 Jan; 29(1):101-110. PubMed ID: 30560716
[TBL] [Abstract][Full Text] [Related]
11. Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma?
Hay ID; Grant CS; Bergstralh EJ; Thompson GB; van Heerden JA; Goellner JR
Surgery; 1998 Dec; 124(6):958-64; discussion 964-6. PubMed ID: 9854569
[TBL] [Abstract][Full Text] [Related]
12. Radioiodine remnant ablation: current indications and dosing regimens.
Haugen BR
Endocr Pract; 2012; 18(4):604-10. PubMed ID: 22849876
[TBL] [Abstract][Full Text] [Related]
13. Selective use of radioactive iodine in the postoperative management of patients with papillary and follicular thyroid carcinoma.
Hay ID
J Surg Oncol; 2006 Dec; 94(8):692-700. PubMed ID: 17131429
[TBL] [Abstract][Full Text] [Related]
14. Long-term surveillance of papillary thyroid cancer patients who do not undergo postoperative radioiodine remnant ablation: is there a role for serum thyroglobulin measurement?
Durante C; Montesano T; Attard M; Torlontano M; Monzani F; Costante G; Meringolo D; Ferdeghini M; Tumino S; Lamartina L; Paciaroni A; Massa M; Giacomelli L; Ronga G; Filetti S;
J Clin Endocrinol Metab; 2012 Aug; 97(8):2748-53. PubMed ID: 22679061
[TBL] [Abstract][Full Text] [Related]
15. Impact of early vs late postoperative radioiodine remnant ablation on final outcome in patients with low-risk well-differentiated thyroid cancer.
Tsirona S; Vlassopoulou V; Tzanela M; Rondogianni P; Ioannidis G; Vassilopoulos C; Botoula E; Trivizas P; Datseris I; Tsagarakis S
Clin Endocrinol (Oxf); 2014 Mar; 80(3):459-63. PubMed ID: 23895145
[TBL] [Abstract][Full Text] [Related]
16. Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period.
Hay ID; Hutchinson ME; Gonzalez-Losada T; McIver B; Reinalda ME; Grant CS; Thompson GB; Sebo TJ; Goellner JR
Surgery; 2008 Dec; 144(6):980-7; discussion 987-8. PubMed ID: 19041007
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of low and intermediate risk differentiated thyroid cancer patients treated with 30mCi for ablation or without radioactive iodine therapy.
Súss SKA; Mesa CO; Carvalho GA; Miasaki FY; Chaves CP; Fuser DC; Corbo R; Momesso D; Bulzico DA; Graf H; Vaisman F
Arch Endocrinol Metab; 2018; 62(2):149-156. PubMed ID: 29641738
[TBL] [Abstract][Full Text] [Related]
18. Impact of primary surgery on outcome in 300 patients with pathologic tumor-node-metastasis stage III papillary thyroid carcinoma treated at one institution from 1940 through 1989.
Hay ID; Bergstralh EJ; Grant CS; McIver B; Thompson GB; van Heerden JA; Goellner JR
Surgery; 1999 Dec; 126(6):1173-81; discussion 1181-2. PubMed ID: 10598204
[TBL] [Abstract][Full Text] [Related]
19. Low versus high activity radioiodine remnant ablation for differentiated thyroid carcinoma with gross extrathyroidal extension invading only strap muscles.
Park SY; Kim HI; Choi JY; Choe JH; Kim JH; Kim JS; Oh YL; Hahn SY; Shin JH; Ahn SH; Kim K; Jeong JG; Kim SW; Chung JH; Kim TH
Oral Oncol; 2018 Sep; 84():41-45. PubMed ID: 30115474
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of radioiodine remnant ablation for differentiated thyroid carcinoma patients with an incomplete thyroidectomy.
Hfu H; Ma C; Li J; Feng F; Wu S; Ye Z; Wang H
Q J Nucl Med Mol Imaging; 2016 Sep; 60(3):280-4. PubMed ID: 25192307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
